{
    "title": "AstraZeneca strikes $400 mln Parkinson's drug deal with Takeda",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4832220/AstraZeneca-strikes-400-mln-Parkinsons-drug-deal-Takeda.html",
    "date": "2017-08-29",
    "keywords": [
        "medi1341",
        "astrazeneca",
        "deal",
        "treatment",
        "cancer",
        "development",
        "company",
        "phase",
        "priority",
        "disease",
        "takeda",
        "neuroscience",
        "area",
        "london",
        "earlystage",
        "medicine",
        "drug",
        "antibody",
        "year",
        "example",
        "expertise",
        "cost",
        "advancement",
        "approach",
        "world",
        "executive",
        "vice",
        "president",
        "pangalos",
        "track",
        "record",
        "monday",
        "berg",
        "intelligence",
        "agreement",
        "tuesday",
        "testing",
        "share",
        "commercialisation",
        "future",
        "revenue",
        "opportunity",
        "oncology",
        "blow",
        "month",
        "immunotherapy",
        "lung",
        "trial",
        "reporting",
        "ben",
        "hirschler",
        "editing",
        "jane",
        "merriman"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}